175 related articles for article (PubMed ID: 32140138)
1. Rational Choice of Antibiotics and Media for
Jaffré J; Aubry A; Maitre T; Morel F; Brossier F; Robert J; Sougakoff W; Veziris N;
Front Microbiol; 2020; 11():81. PubMed ID: 32140138
[TBL] [Abstract][Full Text] [Related]
2. Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
Li Y; Liu C; Ma A; He W; Qiu Q; Zhao Y; Li Y
J Glob Antimicrob Resist; 2022 Dec; 31():90-97. PubMed ID: 35660663
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
He G; Wu L; Zheng Q; Jiang X
Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
[No Abstract] [Full Text] [Related]
4. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
5. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
Maurer FP; Pohle P; Kernbach M; Sievert D; Hillemann D; Rupp J; Hombach M; Kranzer K
Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.
Chazel M; Marchandin H; Keck N; Terru D; Carrière C; Ponsoda M; Jacomo V; Panteix G; Bouzinbi N; Bañuls AL; Choisy M; Solassol J; Aubry A; Godreuil S
Ann Clin Microbiol Antimicrob; 2016 May; 15():30. PubMed ID: 27150659
[TBL] [Abstract][Full Text] [Related]
7. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences.
Morita A; Namkoong H; Uwamino Y; Mitarai S; Aono A; Asakura T; Yagi K; Tanaka H; Azekawa S; Nakagawara K; Kaji M; Nagao G; Kamata H; Matsushita H; Fukunaga K; Hasegawa N
J Infect Chemother; 2024 Feb; 30(2):159-163. PubMed ID: 37717608
[TBL] [Abstract][Full Text] [Related]
8. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
Sirichoat A; Kaewprasert O; Hinwan Y; Faksri K
PLoS One; 2023; 18(11):e0294677. PubMed ID: 37992075
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.
Mok S; Hannan MM; Nölke L; Stapleton P; O'Sullivan N; Murphy P; McLaughlin AM; McNamara E; Fitzgibbon MM; Rogers TR
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262760
[No Abstract] [Full Text] [Related]
11. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
Schön T; Chryssanthou E
Int J Infect Dis; 2017 Feb; 55():122-124. PubMed ID: 28069470
[TBL] [Abstract][Full Text] [Related]
12. Differences in Drug-Susceptibility Patterns between
Fernandez-Pittol M; Batista-Arnau S; Román A; San Nicolás L; Oliver L; González-Moreno O; Martínez JA; Amaro-Rodríguez R; Soler N; Gené A; González-Cuevas A; Tudó G; Gonzalez-Martin J
Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671265
[No Abstract] [Full Text] [Related]
13. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and JustOne strips.
Babady NE; Hall L; Abbenyi AT; Eisberner JJ; Brown-Elliott BA; Pratt CJ; McGlasson MC; Beierle KD; Wohlfiel SL; Deml SM; Wallace RJ; Wengenack NL
J Clin Microbiol; 2010 May; 48(5):1749-52. PubMed ID: 20335412
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W
BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Huang CC; Wu MF; Chen HC; Huang WC
J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
[TBL] [Abstract][Full Text] [Related]
17. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Sharma M; Malhotra B; Khandelwal S
Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
[TBL] [Abstract][Full Text] [Related]
18. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
19. Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.
Woods GL; Williams-Bouyer N; Wallace RJ; Brown-Elliott BA; Witebsky FG; Conville PS; Plaunt M; Hall G; Aralar P; Inderlied C
J Clin Microbiol; 2003 Feb; 41(2):627-31. PubMed ID: 12574258
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ
J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
